Abbott Laboratories (ABT)vsAgnico Eagle Mines Limited (AEM)
ABT
Abbott Laboratories
$84.32
-3.09%
HEALTHCARE · Cap: $151.56B
AEM
Agnico Eagle Mines Limited
$193.21
+2.90%
BASIC MATERIALS · Cap: $93.89B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 233% more annual revenue ($45.13B vs $13.54B). AEM leads profitability with a 39.5% profit margin vs 13.9%. ABT appears more attractively valued with a PEG of 1.29. AEM earns a higher WallStSmart Score of 75/100 (B+).
ABT
Buy56
out of 100
Grade: C
AEM
Strong Buy75
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+0.6%
Fair Value
$87.53
Current Price
$84.32
$3.21 discount
Margin of Safety
-12.6%
Fair Value
$192.97
Current Price
$193.21
$0.24 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Keeps 40 of every $100 in revenue as profit
Strong operational efficiency at 62.8%
Revenue surging 66.1% year-over-year
Earnings expanding 108.6% YoY
Conservative balance sheet, low leverage
Large-cap with strong market position
Areas to Watch
Weak financial health signals
Earnings declined 19.7%
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bull Case : AEM
The strongest argument for AEM centers on Profit Margin, Operating Margin, Revenue Growth. Profitability is solid with margins at 39.5% and operating margin at 62.8%. Revenue growth of 66.1% demonstrates continued momentum.
Bear Case : ABT
The primary concerns for ABT are Piotroski F-Score, EPS Growth.
Bear Case : AEM
The primary concerns for AEM are PEG Ratio.
Key Dynamics to Monitor
ABT profiles as a value stock while AEM is a growth play — different risk/reward profiles.
ABT carries more volatility with a beta of 0.65 — expect wider price swings.
AEM is growing revenue faster at 66.1% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Bottom Line
AEM scores higher overall (75/100 vs 56/100), backed by strong 39.5% margins and 66.1% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Agnico Eagle Mines Limited
BASIC MATERIALS · GOLD · USA
Agnico Eagle Mines Limited is engaged in the exploration, development and production of mineral properties in Canada, Sweden and Finland. The company is headquartered in Toronto, Canada.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?